Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.870
-0.015 (-1.64%)
Apr 29, 2026, 3:19 PM EDT - Market open
Longeveron Revenue
In the year 2025, Longeveron had annual revenue of $1.20M, down -49.87%. Longeveron had revenue of $365.00K in the quarter ending December 31, 2025, a decrease of -39.47%.
Revenue (ttm)
$1.20M
Revenue Growth
-49.87%
P/S Ratio
21.59
Revenue / Employee
$31,553
Employees
38
Market Cap
25.46M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionLGVN News
- 21 days ago - Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs) - GlobeNewsWire
- 6 weeks ago - Longeveron Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Longeveron Announces 2025 Full Year Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Longeveron Braces For Q4 Results Following Recent Funding Boost - Benzinga
- 6 weeks ago - Longeveron Announces Closing of Private Placement of up to $30 Million - GlobeNewsWire
- 7 weeks ago - Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal - Benzinga
- 2 months ago - Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell - GlobeNewsWire
- 2 months ago - Longeveron® Appoints Stephen H. Willard as Chief Executive Officer - GlobeNewsWire